Noul is a medical device company committed to positively impacting over a billion lives by transforming diagnostics with AI-powered, decentralized solutions. Our flagship platform, miLab™, integrates advanced technology to provide rapid, accurate, and accessible diagnostics for critical diseases. We offer MAL for automated malaria detection, including P. falciparum hrp2/hrp3 deletions, BCM for blood cell morphology and CBC testing, and CER for AI-assisted cervical cancer screening using liquid-based cytology. Designed for both central labs and point-of-care settings, miLab™ enhances diagnostic efficiency by reducing manual workload and human error, ensuring fast, reliable results. With a strong commitment to sustainability, Noul develops cost-effective, resource-efficient solutions to improve global healthcare access and empower medical professionals in delivering better patient care.